Trial
NCT02791191
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Alzheimer's Disease
Intervention
LY3202626
Why stopped
Low likelihood of identifying a statistically significant treatment effect.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-19